Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment -: A longitudinal study

被引:35
作者
Gisslén, M
Hagberg, L
Fuchs, D
Norkrans, G
Svennerholm, B
机构
[1] Gothenburg Univ, Dept Infect Dis, Gothenburg, Sweden
[2] Gothenburg Univ, Dept Virol, Gothenburg, Sweden
[3] Univ Innsbruck, Inst Med Chem & Biochem, A-6020 Innsbruck, Austria
[4] Univ Innsbruck, Ludwig Boltzman Inst AIDS Res, A-6020 Innsbruck, Austria
关键词
HIV; cerebrospinal fluid; quantitative polymerase chain reaction; longitudinal study; antiretroviral; naive;
D O I
10.1097/00042560-199804010-00001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV-1 RNA and neopterin levels were observed longitudinally for 20 to 68 months (mean, 37.5 months) in cerebrospinal fluid (CSF) and serum in 15 HIV-1-infected patients not receiving antiretroviral treatment. During the course of infection the HIV-1 RNA levels increased significantly in CSF, from a mean of 3.08 to 3.51 log(10) copies RNA/ml (p < .01). A significant positive correlation was found between the CSF levels of HIV-1 RNA and neopterin (r(s) = 0.54; p < .001), which increased from 13.6 to 19.6 nmol/L (p < .01). No significant changes in HIV-1 RNA or neopterin levels were found in serum. We suggest that the increase of CSF viral load with time in HIV-1 infection triggers an intrathecal immune activation reflected by increased CSF levels of neopterin. These results are in accordance with the theory that a chronic immune stimulation within the central nervous system (CNS) is involved in the pathogenesis of neurologic HIV-1 disease.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 27 条
[1]   QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS, IMMUNE ACTIVATION FACTORS, AND QUINOLINIC ACID IN AIDS BRAINS [J].
ACHIM, CL ;
HEYES, MP ;
WILEY, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2769-2775
[2]   Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage [J].
Brew, BJ ;
Pemberton, L ;
Cunningham, P ;
Law, MG .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :963-966
[3]   Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons [J].
Bruisten, SM ;
Frissen, PHJ ;
VanSwieten, P ;
Harrigan, PR ;
Kinghorn, I ;
Larder, B ;
Weigel, HM ;
DeVries, E ;
Regez, RM ;
Henrichs, JH ;
Koot, M ;
Huisman, JG .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1997, 13 (04) :327-335
[4]  
*CDCP, 1992, MMWR-MORBID MORTAL W, V41, pRR17
[5]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS PRESENT IN THE CEREBROSPINAL-FLUID OF A MAJORITY OF INFECTED INDIVIDUALS [J].
CHIODI, F ;
KEYS, B ;
ALBERT, J ;
HAGBERG, L ;
LUNDEBERG, J ;
UHLEN, M ;
FENYO, EM ;
NORKRANS, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) :1768-1771
[6]   HUMAN IMMUNODEFICIENCY VIRUS-INFECTION OF THE BRAIN .1. VIRUS ISOLATION AND DETECTION OF HIV SPECIFIC ANTIBODIES IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH VARYING CLINICAL CONDITIONS [J].
CHIODI, F ;
SONNERBORG, A ;
ALBERT, J ;
GAINES, H ;
NORKRANS, G ;
HAGBERG, L ;
ASJO, B ;
STRANNEGARD, O ;
FENYO, EM .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1988, 85 (03) :245-257
[7]   CELL-FREE PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TITER ASSESSED BY CULTURE AND IMMUNOCAPTURE-REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION [J].
COOMBS, RW ;
HENRARD, DR ;
MEHAFFEY, WF ;
GIBSON, J ;
EGGERT, E ;
QUINN, TC ;
PHILLIPS, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (08) :1980-1986
[8]  
DAVIS GL, 1994, HEPATOLOGY, V19, P1337, DOI 10.1002/hep.1840190603
[9]  
DiStefano M, 1997, AIDS, V11, P133
[10]   REVERSE-TRANSCRIPTASE SEQUENCE OF PAIRED ISOLATES OF CEREBROSPINAL-FLUID AND BLOOD FROM PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DURING ZIDOVUDINE TREATMENT [J].
DISTEFANO, M ;
SABRI, F ;
LEITNER, T ;
SVENNERHOLM, B ;
HAGBERG, L ;
NORKRANS, G ;
CHIODI, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) :352-355